BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:58 PM
 | 
Mar 31, 2009
 |  BC Extra  |  Company News

GSK to co-promote Shire's Vyvanse

Shire (LSE:SHP; NASDAQ:SHPGY) and GlaxoSmithKline (LSE:GSK; NYSE:GSK) agreed to co-promote Shire's Vyvanse lisdexamfetamine in the U.S. to treat adults with...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >